<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000306508">
  <TermName>MLN2704</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of prostate cancer. It belongs to the family of drugs called antibody drug conjugates. Also called MLN591DM1.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>MLN2704</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer de próstata. Es un tipo de conjugado de anticuerpos. También se llama MLN591DM1.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-05-23</DateFirstPublished>
  <DateLastModified>2006-10-12</DateLastModified>
</GlossaryTerm>
